No abstract available
Publication types
-
Clinical Trial, Phase I
-
Clinical Trial, Phase II
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Bendamustine Hydrochloride
-
Brentuximab Vedotin
-
Hodgkin Disease* / drug therapy
-
Humans
-
Immunoconjugates*
-
Neoplasm Recurrence, Local / drug therapy
-
Progression-Free Survival
Substances
-
Immunoconjugates
-
Brentuximab Vedotin
-
Bendamustine Hydrochloride